Anti-Asthma Short Acting Beta Agonists (SABAs) market

agregó una foto Other

2025-09-30 06:14:16 - Translate

Anti-Asthma Short Acting Beta Agonists (SABAs) market - Trends, Growth, including COVID19 Impact, Forecast

According to a new report from Intel Market Research, the global Anti-Asthma Short Acting Beta Agonists (SABAs) market was valued at USD 13,700 million in 2024 and is projected to reach USD 17,850 million by 2032, growing at a CAGR of 3.9% during the forecast period (2025–2032). This steady growth is underpinned by the persistent global prevalence of asthma, technological advancements in...

0 Commentarios 0 Acciones 218 Views 0 Vista previa